Pharmacogenomics Research and Personalized Medicine (Pharmacogenet Res Per Med; PRPM) is an open-access, international peer-reviewed electronic journal, and openly distributed worldwide. It covers various aspects in the research of pharmacogenomics and personalized medicine, characterizing the influence of genotype on pharmacology, aiming to customize health care, with decisions and treatments tailored to each individual patient in every way possible. It publishes articles that describe advances in basic and translational science, clinical findings and medical trials, in relation to pharmacogenomics and personalized medicine.
As the Official Journal of the Xiangya Hospital Central South University, PRPM aims to provide an international and comprehensive platform for academic and practitioner worldwide to share and exchange ideas as well as to further prompt academic communication domestic and overseas in the field.
Submission Turnaround Time:
Submission to First Editorial Decision: 2-4 weeks.
External Peer Review: 1-3 months.
Acceptance to Publication: 2-4 weeks. Original Articles are listed as priority.
Publisher AME Publishing Company
Address: Flat/RM C 16F, Kings Wing Plaza 1, No. 3 on Kwan Street, Shatin, NT
Phone: +86 20 66355775
Updated date: September 24, 2019